Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine
Authors:
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Advances in Biological Regulation
- Vol. 83, 100857
Abstract
No abstract availableKeywords
Funding Information
- Curtin University, Malaysia
- Curtin Health Innovation Research Institute, Curtin University
- Faculdade de Ciências da Saúde, Universidade de Macau
This publication has 30 references indexed in Scilit:
- Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung CancerPLOS ONE, 2013
- Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular CarcinomaClinical Cancer Research, 2013
- Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral actionCell Death & Differentiation, 2011
- Phenotype and Genotype of Pancreatic Cancer Cell LinesPancreas, 2010
- Midkine: A Novel Prognostic Biomarker for CancerCancers, 2010
- Clinical significance of midkine expression in pancreatic head carcinomaBritish Journal of Cancer, 2007
- Identification of midkine as a mediator for intercellular transfer of drug resistanceOncogene, 2005
- Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide MicroarraysClinical Cancer Research, 2004
- Human pancreatic adenocarcinoma: In vitro and in vivo morphology of a new tumor line established from ascitesIn Vitro Cellular & Developmental Biology - Plant, 1982
- Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreasInternational Journal of Cancer, 1975